evidencegaps
Primary study · included by 1 review

Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer-a systematic review and meta-analysis.

Satapathy 2020 · Satapathy Swayamjeet, Sood Ashwani, Das Chandan Krushna, et al. · Prostate cancer and prostatic diseases · 2021

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.
Non-Cochrane · intervention · 2026 · cited as Satapathy 2020 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.